Public Release: 

Maria Luisa Brandi awarded ESCEO-IOF Servier Pierre D. Delmas Prize

Award presented in Rome to honour researcher's work in cellular and molecular endocrinology as related to bone and mineral metabolism

International Osteoporosis Foundation

Today, at the opening of the European Congress on Osteoporosis & Osteoarthritis in Rome, Italy, Professor Maria Luisa Brandi MD, Professor of Endocrinology and Metabolic Diseases at the University of Florence, Florence, Italy was presented with ESCEO-IOF Servier Pierre D. Delmas Prize.

The prestigious award, valued at €40,000, is granted by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) with the support of Servier.

"This award honours an individual who has made outstanding and major scientific contributions to the study of bone and mineral diseases. We are delighted to present the award to Professor Brandi, one of the most distinguished researchers in the field," said ESCEO President Professor Jean-Yves Reginster.

The award is named after the late Pierre Delmas, the renowned researcher and founding IOF President who was Professor of Medicine and Rheumatology at the University of Lyon, France and Director of the INSERM research unit 'Pathophysiology of Osteoporosis'.

IOF President John A. Kanis commented, "Professor Brandi has made essential contributions to research in clinical and basic bone and mineral metabolism, endocrine tumors, genetics, and in rare skeletal diseases. She has also worked to benefit osteoporosis advocacy in Italy and worldwide in her role as President of F.I.R.M.O. and as an active member of the International Osteoporosis Foundation."

Maria Luisa Brandi, MD/PhD, is Full Professor of Endocrinology and Metabolic Diseases at the University of Florence, Florence, Italy, where she directs the Regional Program on Hereditary Endocrine Tumors and the Bone Metabolic Unit. The Unit is active both in clinical and basic research for bone and mineral metabolic disorders. Her basic background is in molecular endocrinology applied to clinical medicine. She developed several novel cell biological models used in basic research worldwide. Her reputation in the area of bone and mineral metabolism is well recognized nationally and internationally. She owns 7 patents and has published over 450 papers in peer reviewed journals and 200 book chapters. Professor Brandi has been and is the main investigator for several major applications granted from national and international Agencies and Institutions. She was the President of the Italian Society of Osteoporosis, serves as a member of the Scientific Committee of the International Osteoporosis Foundation, is General Secretary of the European Society for Clinical and Economic Aspects of Osteoporosis & Osteoarthritis (ESCEO) and President of the Fondazione Italiana per la Ricerca sulle Malattie dell'Osso. She is the Editor-in-Chief of Clinical Cases in Mineral and Bone Metabolism.

The Pierre Delmas Prize is awarded annually by a prize Committee composed of leading scientists chosen within the IOF Committee of Scientific Advisors and ESCEO Scientific Advisory Board.


About IOF The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related diseases of bone, muscles and joints. IOF members, including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe, share a common vision of a world without musculoskeletal diseases and fragility fractures. IOF now represents more than 200 societies in all regions of the world.

About ESCEO The European Society for Clinical & Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.